Ann: Regeneus and AGC collaborate on Progenza in Japan, page-22

Got a fair few at .185. Happy with that for now as the deal looks to be a cracker!

In fact I haven't seen a deal where the small bio gets such a good outcome. $16.5m cash with $5.5m up front and 50/50 with the major to be responsible for production costs?? Wow...show me a better bio tech deal done in the last year for a company with a $37m MC?? All into a huge Japan market. Don't know the ins and outs of this coy but that deal is too good not to buy in on imo. DYOR